This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Servier, Mylan, Teva spar with EU regulator over patent settlements at bloc's top court

By Nicholas Hirst ( October 20, 2021, 17:20 GMT | Insight) -- Les Laboratoires Servier and the European Commission clashed today at the EU's top court over patent settlement deals that prompted hundreds of millions of euros of fines. The French drug company is trying to fully overturn EU fines that were partially upheld by the lower-tier General Court in 2018, over agreements with makers of generic drugs including Mylan, Teva and Lupin.Les Laboratoires Servier and the European Commission clashed today at the EU's top court over patent settlement deals that prompted hundreds of millions of euros of fines....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections